Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Dec 15, 2010


Epigenomics announced this week that Oliver Schacht, its current chief financial officer, has decided to leave the company after working there for nearly 13 years.

"We are very pleased that we already have found and signed-up a new chief financial officer, who will join the management team by April 1, 2011," Epigenomics said in a statement. However, due to the new hire's current obligations, Epigenomics will disclose the CFO's name in the first weeks of January 2011.

Schacht and the new CFO will work together during the first quarter to "ensure a smooth transition," Epigenomics said.

J&J has put out a call for nominations for its 2011 Dr. Paul Janssen Award for Biomedical Research. The $100,000 award recognizes scientists in academic and industrial research in the field of biomedical engineering, "whose efforts have made transformational contributions towards the improvement of human health."

Nomination forms are available here and will be accepted until February 15, 2011. The winner will be announced in the second half of next year.

Nominees will be evaluated by an independent selection committee of researchers from around the world. Past winners of the award include Anthony Fauci, Erik De Clercq, Craig Mello, Axel Ullrich, Marc Feldmann, and Ravinder Maini.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.